-

Northlane Capital Partners Announces the Sale of Empower Community Care

BETHESDA, Md.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today the sale of Empower Community Care (“Empower” or the “Company”) to NexPhase Capital, LP (“NexPhase”).

Founded in 2016, Empower is an established global behavioral health organization offering proprietary treatments and services to help at-risk youth, their families, and caregivers. The Company does not directly administer the treatment but instead provides its state and municipal clients with training and support for scientifically proven, community-based interventions, software-based assessment and case management tools, and assistance with the selection, implementation, and supervision of evidence-based programs. Additional information is available at https://www.empowercommunitycare.com/.

Eugene Krichevsky, Partner at NCP, said, “It’s been a privilege to partner with Josh Glade and the Empower team in building a mission-driven organization that delivers high-impact, evidence-based programming to youth and families across the country and throughout the world. Since our investment in 2021, the Company has enhanced its growth trajectory through service line expansion, strategic acquisitions, and key personnel additions. We believe Empower is well-positioned for continued growth and wish the team success during this next chapter.”

“NCP has been a valued partner, and we are thankful for their strategic support over the past several years,” said Josh Glade, CEO of Empower. “With the dedicated support and resources that the NCP team provided, we expanded our evidence-based service offerings and proprietary product lines, ultimately accelerating our ability to improve services available to vulnerable populations. We are excited to work with the NexPhase team to build on our momentum and expand the reach of our evidence-based programs to even more youth, families, and communities worldwide.”

Scott Kauffman, Partner at NCP, added, “Our successful investment in Empower is a direct result of our thesis and research within the non-provider, behavioral health space. In 2023, Empower won the inaugural Healthcare Private Equity Association Impact Award, recognizing it as a company making significant contributions in critically important areas in healthcare delivery. Empower illustrates how private equity can support leading companies to serve our communities in meaningful ways.”

ABOUT NORTHLANE CAPITAL PARTNERS

Based in Bethesda, MD, NCP is a middle market private equity firm focused on key segments within the healthcare and business services sectors, where its principals have invested $1.8 billion of equity capital. NCP’s strategy is to partner with industry leading companies and great management teams, aligning incentives to accelerate growth and build value. For more information, please visit www.northlanecapital.com.

Contacts

NCP Contacts

Eugene Krichevsky, Partner
(301) 841-1399

Scott Kauffman, Partner
(301) 968-9227

Anna Ellingboe, Vice President
(301) 272-9992

Northlane Capital Partners


Release Versions

Contacts

NCP Contacts

Eugene Krichevsky, Partner
(301) 841-1399

Scott Kauffman, Partner
(301) 968-9227

Anna Ellingboe, Vice President
(301) 272-9992

More News From Northlane Capital Partners

SAI MedPartners Enhances Its Competitive Intelligence Capabilities Through the Acquisition of The Dunn Group

READING, Pa.--(BUSINESS WIRE)--SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired The Dunn Group (“TDG”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022. TDG, headquartered in Totowa, NJ, is a competitive intelligence firm that focuses on providing primary business intelligence to clients in the pharmaceu...

Northlane Capital Partners Announces Final Close of Oversubscribed Fund III at $750 Million

BETHESDA, Md.--(BUSINESS WIRE)--Northlane Capital Partners (“Northlane” or “NCP”) announced today the final closing of its oversubscribed third private equity fund, Northlane Capital Partners III LP (“NCP III” or “Fund III”), at its hard cap of $750 million. The total raised substantially surpassed Fund III’s $550 million target and reflects notable growth from its $408 million predecessor. Global investors include pension funds, insurance companies, endowments and foundations, asset managers,...

Northlane Capital Partners Announces the Sale of The Difference Card

BETHESDA, Md.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today the sale of The Difference Card (“TDC” or the Company) to funds managed by Stone Point Capital LLC. Founded in 2001, TDC is a provider of healthcare cost containment solutions that enable employers to reduce healthcare insurance costs without reducing employees’ benefit levels or increasing employees’ out-of-pocket expenses. By utilizing card technology, risk transfer solutions, and proprietary wellness strategie...
Back to Newsroom